Immunotherapy Active Against Triple-Negative Breast Cancer

October is breast cancer awareness month and patients with triple-negative breast cancer TNBC should be aware that data from two clinical trials provide additional evidence that they may derive benefit from checkpoint inhibitor therapy1-4 About Triple Neg [...]

LynparzaTM Slows Spread of Inherited Breast Cancer Caused By BRCA Mutations

LynparzaTM olaparib a new drug treatment for women with advanced ovarian cancer associated with defective BRCA genes also appears to slowe the progression of breast cancer caused in part by mutations in the BRCA gene BRCA is an inherited condition that ca [...]

FDA approves new treatment for certain advanced or metastatic breast cancers

The US Food and Drug Administration today approved Verzenio abemaciclib to treat adult patients who have hormone receptor HR-positive human epidermal growth factor receptor 2 HER2-negative advanced or metastatic breast cancer that has progressed after tak [...]